Hinge Health, Inc. Class A Common Stock (HNGE)
R&D to Revenue
16.00%
Quarterly · Period ending:
HNGE R&D to Revenue
Latest reported16.00%period ending
Latest reported16.00%period ending
HNGE Quarterly R&D/Revenue (39.80% → 16.00%)
Latest values, visible window
High-resolution chart · PNG
HNGE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16.003% | |
| 16.6412% | |
| 19.1857% | |
| 20.6996% | |
| 201.2696% | |
| 18.9784% | |
| 19.0788% | |
| 23.6396% | |
| 27.7428% | |
| 37.1947% | |
| 35.0556% | |
| 34.9801% | |
| 39.8036% |